tst Biomedical Electronics
私たちについて
tst biomedical electronics co. ltd., an innovative Taiwan-based biomedical electronics spin-off founded in 2018 by Tai-Saw Technology Co., Ltd., stands at the forefront of excellence in providing cutting-edge Surface Acoustic Waves (SAW) Open Platform Services. Since 2021, tst biomedical has demonstrated outstanding achievement by delivering the SAW Platform to diverse partners, showcasing a commitment to technological advancement.
Harnessing the core SAW technology from TST and collaborating with strategic partner Japan Radio Co., Ltd. (JRC), tst biomedical proudly presents "iProtin" – a robust SAW biosensor platform designed for exceptional Point of Care Testing (POCT) applications in both home and clinic settings. This innovative solution reflects our dedication to advancing healthcare technology.
Beyond iProtin, tst biomedical extends its impact by offering a comprehensive range of biomedical devices, effectively addressing the burgeoning demand for health management in our community. This multifaceted approach underscores our commitment to improving lives through cutting-edge biomedical innovations.
私たちの価値観
At the forefront of tst biomedical's groundbreaking endeavors is the iProtin Reader, a cutting-edge diagnostic solution targeting major biomarkers such as CRP, Lp(a), and ApoB. Designed to facilitate on-site and rapid testing, iProtin Reader serves the critical healthcare needs of patients and residents within hospitals, nursing homes, and long-term care centers around the world. Its comprehensive biomarker analysis, focusing on pre-screening for heart health and lipid management, stands as a testament to its potential in effectively monitoring and ameliorating the risks associated with atherosclerotic cardiovascular diseases (ASCVD) and related ailments.
Acknowledging the pivotal role of collaborative partnerships in market penetration, tst biomedical is poised for strategic alliances with global distributors. This collaborative effort aims to bolster clinical laboratory medicine support and secure reimbursements in accordance with the List of local Insurance Codes. Notably, both the device and its accompanying test cartridges have obtained FDA clearance and listing, underscoring the commitment to regulatory compliance.